AU2176597A - Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain - Google Patents

Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain

Info

Publication number
AU2176597A
AU2176597A AU21765/97A AU2176597A AU2176597A AU 2176597 A AU2176597 A AU 2176597A AU 21765/97 A AU21765/97 A AU 21765/97A AU 2176597 A AU2176597 A AU 2176597A AU 2176597 A AU2176597 A AU 2176597A
Authority
AU
Australia
Prior art keywords
tetrahydroisoquinolines
psychosis
dialkyl
pain
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21765/97A
Inventor
Masaaki Hirobe
Yoshikazu Masukawa
Shigeru Ohta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Japan Inc
Original Assignee
Lederle Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lederle Japan Ltd filed Critical Lederle Japan Ltd
Publication of AU2176597A publication Critical patent/AU2176597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU21765/97A 1996-03-29 1997-03-28 Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain Abandoned AU2176597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9966696 1996-03-29
JP8-99666 1996-03-29
PCT/JP1997/001062 WO1997036588A2 (en) 1996-03-29 1997-03-28 Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain

Publications (1)

Publication Number Publication Date
AU2176597A true AU2176597A (en) 1997-10-22

Family

ID=14253366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21765/97A Abandoned AU2176597A (en) 1996-03-29 1997-03-28 Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain

Country Status (3)

Country Link
JP (1) JP2000507569A (en)
AU (1) AU2176597A (en)
WO (1) WO1997036588A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9127306D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
WO1997036588A3 (en) 1997-12-24
JP2000507569A (en) 2000-06-20
WO1997036588A2 (en) 1997-10-09

Similar Documents

Publication Publication Date Title
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
HRP960365B1 (en) New medicaments and the use thereof
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
IL128850A0 (en) Medical treatment
HUP0100042A3 (en) Benzofuran carboxamides medicaments containing the same and their therapeutic use
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5802196A (en) Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
HUP0002030A3 (en) Use of glur5 receptorantagonists for the treatment of pain
AU2508597A (en) Drug for the treatment of tumours
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
GB9414157D0 (en) Medical use
ZA977606B (en) Antimicrobial medical devices and methods of production and use.
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
GB9521725D0 (en) Medical treatment
GB9614578D0 (en) Medical treatment
AU2462097A (en) The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
AU2176597A (en) Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain
GB9408084D0 (en) Medical treatment
GB9526264D0 (en) Medical treatment
AU3300397A (en) Cyclin-c variants, and diagnostic and therapeutic uses thereof
AU3885995A (en) Novel medicinal use
AU1014997A (en) A drug for the treatment of cancer
GB9601042D0 (en) Medical use